ALLO
Allogene Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.69
−2.31%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.13
- Revenue estimate
- $2.5K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.13
- EPS estimate
- -$0.17
- Revenue actual
- —
- Revenue estimate
- $2.5K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +17.9%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.17 | -$0.13 | Beat 24.14% | — |
| May 13, 2026 | -$0.19 | -$0.18 | Beat 5.26% | — |
| Mar 12, 2026 | -$0.23 | -$0.17 | Beat 24.62% | — |
| Nov 6, 2025 | -$0.23 | -$0.19 | Beat 17.39% | — |
| Aug 13, 2025 | -$0.28 | -$0.23 | Beat 17.86% | — |
| Mar 13, 2025 | -$0.34 | -$0.28 | Beat 17.65% | $22.0K |
| Nov 7, 2024 | -$0.34 | -$0.27 | Beat 20.59% | — |
| Mar 14, 2024 | -$0.47 | -$0.43 | Beat 8.51% | $21.0K |
| Nov 2, 2023 | -$0.53 | -$0.37 | Beat 30.19% | $43.0K |
| Aug 2, 2023 | -$0.59 | -$0.53 | Beat 10.17% | $44.0K |
| May 3, 2023 | -$0.63 | -$0.68 | Miss -7.94% | $52.0K |
| Feb 28, 2023 | -$0.71 | -$0.66 | Beat 7.04% | $47.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026